Washington University researcher receives $300,000 grant to study AMD
February 19th 2024Rajendra Apte, MD, PhD, has received the Research to Prevent Blindness /American Macular Degeneration Foundation Catalyst Award for innovative research approaches in studying age-related macular degeneration.
Read More
Kathryn A. Colby, MD, PhD, looks to the future in ophthalmology and at NYU
February 16th 2024David Hutton of Ophthalmology Times talks with Kathryn A. Colby, MD, PhD, Elisabeth J. Cohen Professor and Chair, NYU Langone Department of Ophthalmology, about the year the department had in 2023 as well as an outlook at advancements in the field of ophthalmology moving forward.
Read More
Groups: New prior authorization rule could reduce physicians’ burden, improve patient care
February 14th 2024The rule comes as health insurers have increasingly been criticized for onerous and time-consuming prior authorization procedures that physicians say unfairly delay or deny the medical treatment that their patients need
Read More
The Fred Hollows Foundation outlines 5-year strategy
February 14th 2024In the next strategic period, The foundation is hoping to scale its programs to make the largest contribution to date. This includes tackling the key barriers to eye health, including chronic workforce shortages across all areas of health, especially in remote regions, and the availability, quality and use of eye health data.
Read More
EyeBio announces positive data from first-in-human Ph1b/2a AMARONE trial of Restoret for DME, DVAMD
February 14th 2024Twelve-week data from the Ph1b/2a AMARONE trial reveals Restoret to be well-tolerated in patients with diabetic macular edema and neovascular age-related macular degeneration.
Read More
FDA approves Eyenovia’s Redwood City commercial manufacturing facility
February 13th 2024According to a news release, the Redwood City, California, site will complement Eyenovia’s facility in Reno, Nevada as well as its contract manufacturer, Coastline International, to produce commercial supply of Mydcombi.
Read More
Kiora Pharmaceuticals CEO discusses partnership with Théa Open Innovation and pipeline updates
February 12th 2024David Hutton of Ophthalmology Times talks with Brian Strem, PhD, CEO Kiora Pharmaceuticals, about their recent partnership with Théa Open Innovation and further development of their KIO-301 and KOI-104 programs.
Read More
Study examines the influence of the cellular environment on vision
February 10th 2024Researchers noted a study by Ruhr-University Bochum researchers provides crucial evidence that the ECM influences visual sensory motor behavior already at the retina level, without intervention of disease and/or experimental manipulation.
Read More
Glaucoma 360: Innovations in glaucoma drugs and drug delivery
February 10th 2024Joseph Panarelli, MD, sat down with David Hutton of Ophthalmology Times to discuss the panel he moderated at the Glaucoma 360 meeting held in San Francisco, about innovations in glaucoma drugs, and drug delivery.
Read More
H. Dunbar Hoskins Jr., MD, passes away at 84
February 8th 2024Hoskins was a pioneer and leader in the field of ophthalmology and glaucoma, and served as executive vice president of the American Academy of Ophthalmology, founding director and Director Emeritus of the Glaucoma Research Foundation, and a founding director of the American Glaucoma Society.
Read More